Three of the major four orthopedic device companies beat analyst expectations in the second quarter of 2020 as procedure volumes began recovering. While expectations remain high for orthopedics makers that procedure volumes will continue its upward trend, the ongoing COVID-19 pandemic creates a lot of uncertainties.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?